COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 2663: Articles 26621-26630  | Next

The SARS-CoV-2 pandemic course in Saudi Arabia: A dynamic epidemiological model
Al-Khani, A. M., Khalifa, M. A., AlMazrou, A., Saquib, N.
10.1101/2020.06.01.20119800 — Posted: 2020-06-02
Performance of suspected influenza case definitionbefore and during the COVID-19 pandemic
Murillo-Zamora, E., HERNANDEZ-SUAREZ, C. M.
10.1101/2020.06.01.20119446 — Posted: 2020-06-02
Global between-countries variance in SARS-CoV-2 mortality is driven by reported prevalence, age distribution, and case detection rate
Babacic, H., Lehtiö, J., Pernemalm, M.
10.1101/2020.05.28.20114934 — Posted: 2020-06-02
Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19 - a prospective cohort study
eugen-olsen, j., Altintas, I., Tingleff, J., Stauning, M., Gamst-Jensen, H., Lindstroem, M. B., Rasmussen, L. J. H., Kristiansen, K. T., Rasmussen, C., Nehlin, J., Kallemose, T., Andersen, O.
10.1101/2020.05.27.20114678 — Posted: 2020-06-02
An open resource for T cell phenotype changes in COVID-19 identifies IL-10-producing regulatory T cells as characteristic of severe cases
Neumann, J., Prezzemolo, T., Vanderbeke, L., Roca, C. P., Gerbaux, M., Janssens, S., Willemsen, M., Burton, O., Van Mol, P., Van Herck, Y., CONTAGIOUS co-authors, , Wauters, J., Wauters, E., Liston, A., Humblet-Baron, S.
10.1101/2020.05.31.20112979 — Posted: 2020-06-02 Discussion: Onsite | Offsite
Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3
Yoshimi, K., Takeshita, K., Yamayoshi, S., Shibumura, S., Yamauchi, Y., Yamamoto, M., Yotsuyanagi, H., Kawaoka, Y., Mashimo, T.
10.1101/2020.06.02.20119875 — Posted: 2020-06-02
High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay
McDade, T. W., McNally, E., Zelikovich, A., D'Aquila, R., Mustanski, B., Miller, A., Vaught, L., Reiser, N., Bogdanovic, E., Fallon, K., Demonbreun, A.
10.1101/2020.06.01.20119602 — Posted: 2020-06-02
Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study
Wang, Q., Guo, H., Li, Y., Jian, X., Hou, X., Zhong, N., Fei, J., Su, D., Bian, Z., Zhang, Y., Hu, Y., Sun, Y., Yu, X., Li, Y., Jiang, B., Li, Y., Qin, F., Wu, Y., Gao, Y., Hu, Z.
10.1101/2020.05.29.20114223 — Posted: 2020-06-02 Discussion: Onsite
Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon.
Chamieh, A., Afif, C., El-Hajj, G., Zmerli, O., Djaffar-Jureidini, I., Raad, R. A., Ashou, R., Juvelekian, G., Rolain, J.-M., Azar, E.
10.1101/2020.05.28.20114835 — Posted: 2020-06-02
Correlation of the global spread of coronavirus disease-19 with atmospheric air temperature
Bezabih, Y. M., Mequanint, A., alamneh, E., Bezabih, A., Sabiiti, W., Roujeinikova, A., Bezabhe, W.
10.1101/2020.05.27.20115048 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).